Prescription drug · NDA
Viberzi (Eluxadoline) NDC 61874-075
Eluxadoline 75 mg/1 · Tablet, Film coated · Oral · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 61874-075-16 | 61874007516 | 2 BLISTER PACK in 1 CARTON (61874-075-16) / 8 TABLET, FILM COATED in 1 BLISTER PACK (61874-075-08)Marketed from Jan 1, 2026 · Sample package | |
| 61874-075-60 | 61874007560 | 1 BOTTLE in 1 CARTON (61874-075-60) / 60 TABLET, FILM COATED in 1 BOTTLEMarketed from Oct 1, 2015 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Viberzi
- Generic name (nonproprietary)
- eluxadoline
- Active ingredients
- Eluxadoline — 75 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Allergan, Inc.NDC labeler code 61874
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 206940
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Opioid mu-Receptor Agonists (Mechanism)
- Identifiers
- Product ID 61874-075_50b9e7bd-c577-4562-9d26-1d8dcb8cf2efSPL ID 50b9e7bd-c577-4562-9d26-1d8dcb8cf2efSPL set ID 7821bd40-4c84-4984-951b-6436ae20421aRxCUI 1653786, 1653792, 1719764, 1719766UNII 45TPJ4MBQ1UPC 0361874075601
- Pharmacologic class
- mu-Opioid Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N461874007516followed by a unit qualifier and the quantityPackage 61874-0075-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
VIBERZI is indicated in adults for the treatment of irritable bowel syndrome with diarrhea (IBS-D). VIBERZI is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhea (IBS-D). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 61874-075
- What is NDC 61874-075?
- 61874-075 is the product NDC for Viberzi (eluxadoline), Eluxadoline 75 mg/1 tablet, film coated, listed with the FDA by Allergan, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Viberzi (Eluxadoline).
- What is the active ingredient?
- Eluxadoline.
- Who is the labeler?
- Allergan, Inc., NDC labeler code 61874. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Viberzi?
- 1 other product NDC are listed under this name. See all Viberzi NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Viberzi products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Viberzieluxadoline | Eluxadoline 100 mg/1 | Tablet, Film coatedOral | Allergan, Inc. | 61874-100 | 61874-0100-1661874-0100-60 |
Other NDCs under NDA 206940
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Viberzieluxadoline | Eluxadoline 100 mg/1 | Tablet, Film coatedOral | Allergan, Inc. | 61874-100 |